中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
3期
24-24,26
,共2页
肺结核%大咯血%蛇毒血凝酶%临床效果%不良反应
肺結覈%大咯血%蛇毒血凝酶%臨床效果%不良反應
폐결핵%대각혈%사독혈응매%림상효과%불량반응
Pulmonary tuberculosis%Hemoptysis%Hemocoagulase%Clinical effect%Adverse reaction
目的：观察评价蛇毒血凝酶治疗肺结核大咯血的临床疗效与安全性。方法：收治肺结核大咯血患者24例，回顾性分析其临床资料，选择垂体后叶素+硝酸甘油止血的12例纳入对照组，选择蛇毒血凝酶肌注的12例纳入观察组，对比相关指标。结果：观察组起效时间(5±1)min，咯血消失时间(2±2)h，咯血量(310±207)mL，低于对照组的(14±9)min、(28±15)h、(582±174)mL；观察组住院期间复发率0、不良反应发生率0，低于对照组的41.67%、50.00%，差异均有统计学意义(P＜0.05)。结论：以蛇毒血凝酶治疗肺结核大咯血，止血速度快、1次成功率高、复发率低、不良反应少、操作简单，是一种理想的肺结核大咯血止血剂，但使用时需具有一定预见性。
目的：觀察評價蛇毒血凝酶治療肺結覈大咯血的臨床療效與安全性。方法：收治肺結覈大咯血患者24例，迴顧性分析其臨床資料，選擇垂體後葉素+硝痠甘油止血的12例納入對照組，選擇蛇毒血凝酶肌註的12例納入觀察組，對比相關指標。結果：觀察組起效時間(5±1)min，咯血消失時間(2±2)h，咯血量(310±207)mL，低于對照組的(14±9)min、(28±15)h、(582±174)mL；觀察組住院期間複髮率0、不良反應髮生率0，低于對照組的41.67%、50.00%，差異均有統計學意義(P＜0.05)。結論：以蛇毒血凝酶治療肺結覈大咯血，止血速度快、1次成功率高、複髮率低、不良反應少、操作簡單，是一種理想的肺結覈大咯血止血劑，但使用時需具有一定預見性。
목적：관찰평개사독혈응매치료폐결핵대각혈적림상료효여안전성。방법：수치폐결핵대각혈환자24례，회고성분석기림상자료，선택수체후협소+초산감유지혈적12례납입대조조，선택사독혈응매기주적12례납입관찰조，대비상관지표。결과：관찰조기효시간(5±1)min，각혈소실시간(2±2)h，각혈량(310±207)mL，저우대조조적(14±9)min、(28±15)h、(582±174)mL；관찰조주원기간복발솔0、불량반응발생솔0，저우대조조적41.67%、50.00%，차이균유통계학의의(P＜0.05)。결론：이사독혈응매치료폐결핵대각혈，지혈속도쾌、1차성공솔고、복발솔저、불량반응소、조작간단，시일충이상적폐결핵대각혈지혈제，단사용시수구유일정예견성。
Objective:To observe and evaluate the clinical effect and security of hemocoagulase in the treatment of pulmonary tuberculosis hemoptysis.Methods:24 patients with pulmonary tuberculosis hemoptysis were selected.The clinical data were retrospectively analyzed.12 cases of hypophysin + nitroglycerin bleeding were selected as the control group.12 cases of hemocoagulase intramuscular were selected as the observation group.The related indicators were compared.Results:The onset time of the observation group (5±1)minutes,the haemoptysis disappeared time (2±2)hours,the amount of hemoptysis (310±207) mL were lower than (14±9)minutes,(28±15)hours and (582±174)mL of the control group.The recurrence rate 0.00% and the adverse reaction incidence rate 0.00% of the observation group during hospitalization were lower than 41.67% and 50.00% of the control group.The differences were statistically significant(P<0.05).Conclusion:The hemocoagulase in the treatment of pulmonary tuberculosis hemoptysis has quickly hemostatic speed and high first time success rate,low recurrence rate and less adverse reaction.The operation is simple.It is ideal pulmonary tuberculosis hemoptysis hemostatic agent,but its use needs to have a certain predictability.
